Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Atiya Khan

Neurology with Special Qualifications in Child Neurology Fort Wayne, IN Medical Doctor

NPI 1881691368 CMS profile 266714

11115 Parkview Plaza Dr, Fort Wayne, IN 46845

Open in the dashboard

General payments

$1,203,578

1,971 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Atiya Khan of Fort Wayne, IN is reported in the CMS Open Payments database as having received $1,203,578 across 1,971 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $241,862 398
2024 General $235,275 344
2023 General $173,962 259
2022 General $210,328 301
2021 General $131,308 211
2020 General $47,934 114
2019 General $162,910 344

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Atiya Khan
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Atiya Khan were reported at $241,862. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Atiya Khan Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $162,910 $262 $68–$1,313 $163
2020 $47,934 $188 $46–$1,222 $114
2021 $131,308 $183 $45–$1,356 $132
2022 $210,328 $229 $72–$1,177 $149
2023 $173,962 $269 $93–$1,195 $160
2024 $235,275 $300 $98–$1,428 $164
2025 $241,862 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. UCB, Inc. $348,233 627 payments
  2. Neurelis, Inc. $243,574 310 payments
  3. Jazz Pharmaceuticals Inc. $200,936 239 payments
  4. Eisai Inc. $155,299 216 payments
  5. SK Life Science, Inc. $84,785 114 payments
  6. Catalyst Pharmaceuticals, Inc. $70,755 94 payments
  7. Greenwich Biosciences, Inc. $46,706 68 payments
  8. Aquestive Therapeutics, Inc. $28,257 59 payments
  9. Sunovion Pharmaceuticals Inc. $10,003 78 payments
  10. LivaNova USA, Inc. $9,543 28 payments
  11. Other $5,489 138 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $885,451 430 payments
  2. Honoraria $138,251 68 payments
  3. Travel and Lodging $93,387 473 payments
  4. Consulting Fee $44,965 50 payments
  5. Food and Beverage $41,418 940 payments
  6. Education $106 10 payments
Products named General payments · program years 2019–2025
  1. Epidiolex $247,311 300 payments
  2. VALTOCO $243,574 310 payments
  3. Fycompa Neurology $154,432 214 payments
  4. Briviact $149,834 293 payments
  5. Fintepla $104,551 176 payments
  6. Nayzilam $83,243 128 payments
  7. XCOPRI $71,436 88 payments
  8. FYCOMPA Neurology $70,603 93 payments
  9. SYMPAZAN $28,216 57 payments
  10. Cenobamate $12,679 12 payments
  11. Other $25,957 265 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,971 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record